Literature DB >> 18266670

Prognostic value of signal-averaged electrocardiogram in Chagas disease.

Antonio Luiz Pinho Ribeiro1, Paulo Sérgio Cavalvanti, Federico Lombardi, Maria do Carmo Pereira Nunes, Márcio Vinícius Lins Barros, Manoel Otávio da Costa Rocha.   

Abstract

BACKGROUND: The value of signal-averaged ECG (SAECG) in the risk stratification of Chagas disease (ChD), a potentially lethal illness prevalent in Latin America, remains controversial. The aim of this prospective longitudinal study was to determine the prognostic value of SAECG in ChD, using multivariate models with other established prognostic predictors, and to develop a simple prediction risk score.
METHODS: The study enrolled 184 ambulatory ChD patients (107 men; age: 48 +/- 12 years) in sinus rhythm and without other systemic diseases. All patients underwent comprehensive evaluation that included clinical examination, ECG, chest X-ray, 24-hour Holter monitoring, echocardiogram, stress testing, and time domain SAECG. Individual medical therapy was adjusted according to a standardized treatment regimen. The association of potential risk factors obtained by noninvasive evaluation and death was tested by Cox proportional-hazards analysis.
RESULTS: During mean follow-up time of 74 +/- 17 months, 13 patients died. Three independent prognostic factors were identified: left ventricular ejection fraction <50% (HR = 5.2, P = 0.048), ventricular tachycardia at either Holter monitoring or stress testing (HR = 9.9, P = 0.036), and prolonged (>150 ms) filtered QRS complex (HR = 4.3, P = 0.035). A prognostic score developed considering the number of risk factors of each patient had an excellent performance in predicting death (c statistic: 0.92).
CONCLUSIONS: Prolonged filtered QRS duration obtained by SAECG is an independent predictor of death in ChD. A prediction score including three risk factors, depressed left ventricular ejection fraction, ventricular tachycardia and prolonged filtered QRS complex, has shown to be useful for stratifying risk categories in ChD.

Entities:  

Mesh:

Year:  2008        PMID: 18266670     DOI: 10.1111/j.1540-8167.2007.01088.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  18 in total

1.  Low noise level unmasks late potentials on signal-averaged electrocardiography.

Authors:  Raul J Frances
Journal:  Exp Clin Cardiol       Date:  2010

2.  Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status.

Authors:  Héctor Rodríguez-Angulo; Juan Marques; Ivan Mendoza; Marco Villegas; Alfredo Mijares; Núria Gironès; Manuel Fresno
Journal:  BMC Infect Dis       Date:  2017-03-21       Impact factor: 3.090

3.  The challenge of risk assessment in the riddle of Chagas heart disease.

Authors:  José Antonio Marin-Neto; Anis Rassi
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-06-06       Impact factor: 2.747

Review 4.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

5.  Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.

Authors:  Ester C Sabino; Antonio L Ribeiro; Vera M C Salemi; Claudia Di Lorenzo Oliveira; Andre P Antunes; Marcia M Menezes; Barbara M Ianni; Luciano Nastari; Fabio Fernandes; Giuseppina M Patavino; Vandana Sachdev; Ligia Capuani; Cesar de Almeida-Neto; Danielle M Carrick; David Wright; Katherine Kavounis; Thelma T Goncalez; Anna Barbara Carneiro-Proietti; Brian Custer; Michael P Busch; Edward L Murphy
Journal:  Circulation       Date:  2013-02-07       Impact factor: 29.690

Review 6.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

7.  Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.

Authors:  Jessica E Yager; Daniel F Lozano Beltran; Faustino Torrico; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

8.  Predictive factors for the progression of chronic Chagas cardiomyopathy in patients without left ventricular dysfunction.

Authors:  Silvana de Araújo Silva; Eliane Dias Gontijo; João Carlos Pinto Dias; Camila Gomes de Souza Andrade; Carlos Faria Santos Amaral
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

9.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

10.  Utility of a novel risk score for prediction of ventricular tachycardia and cardiac death in chronic Chagas disease - the SEARCH-RIO study.

Authors:  P R Benchimol-Barbosa; B R Tura; E C Barbosa; B K Kantharia
Journal:  Braz J Med Biol Res       Date:  2013-10-22       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.